DCF — SUTTER SOLANO MEDICAL CENTER
Enterprise Value: $-235.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-235.1M
Enterprise Value
$-74.6M
PV of Cash Flows
$-160.5M
PV of Terminal Value
$-258.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $154.7M | $-14.5M | -9.0% | $-21.1M | $-19.1M |
| Year 2 | $159.4M | $-13.3M | -8.0% | $-20.1M | $-16.6M |
| Year 3 | $164.2M | $-12.1M | -7.0% | $-19.1M | $-14.3M |
| Year 4 | $169.1M | $-11.6M | -7.0% | $-18.8M | $-12.8M |
| Year 5 | $174.2M | $-11.5M | -7.0% | $-18.9M | $-11.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-235.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$150.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09874474878018498
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5